Home > Healthcare > Drug Device Combination > Drug Filled Devices > Ureteral Stents Market

Ureteral Stents Market Analysis

  • Report ID: GMI8522
  • Published Date: Mar 2024
  • Report Format: PDF

Ureteral Stents Market Analysis

The market by product type is categorized into double pigtail, open-ended, close-ended, and multiloop. The double pigtail segment dominates the market with a revenue of around USD 177.8 million in 2023.
 

  • A double pigtail design is a distinctive feature in some ureteral stents where the ends of the stent curl into a double-looped or pigtail configuration. This design serves multiple purposes. The double pigtail helps anchor the stent in place within the kidney and bladder, reducing the risk of migration. Additionally, the coiled ends reduce irritation and trauma to the surrounding tissues, enhancing patient comfort during stent placement. This design innovation has become a hallmark of ureteral stents, contributing to their widespread use and acceptance in urological interventions.  
     
  • Moreover, the double-pigtail configuration effectively addresses the stent migration issue. The curled ends of the stent function as barriers, preventing unintentional movement within the ureter. This feature is particularly crucial in ensuring the longevity of the stent's therapeutic effects and reducing the need for frequent repositioning or replacement.
     

The ureteral stents market by application is categorized into kidney stones, kidney transplant, urinary tract infection, and other applications. The kidney stones segment dominates the market with a revenue of around USD 158 million in 2023.
 

  • Kidney stones can obstruct the normal flow of urine, causing excruciating pain and discomfort. Ureteral stents are often employed to alleviate this obstruction, allowing the natural passage of urine. By providing a temporary bypass for urine flow, stents effectively relieve the pain associated with kidney stones, making them a crucial component in the immediate management of this condition.
     
  • Surgical interventions, such as ureteroscopy or percutaneous nephrolithotomy, are often necessary for the removal of large or stubborn kidney stones. Ureteral stents are commonly placed postoperatively to promote healing, reduce swelling, and maintain the patency of the ureters. This application enhances the recovery process, underscoring the integral role of ureteral stents in comprehensive care for kidney stone patients, driving segment growth.
     

Based on the material, the ureteral stents market is segmented into metal stents, polyurethane stents, silicon stents, and hydrogel stents. The metal stents segment is anticipated to reach USD 289.5 million by 2032.
 

  • Metal stents, often made from alloys like nitinol or stainless steel, are known for their durability and long-lasting characteristics. This longevity is particularly beneficial in situations where extended stent indwelling times are required, such as in cases of chronic obstruction or recurrent urological conditions. The extended lifespan of metal stents enhances patient convenience by reducing the frequency of stent replacement.
     
  • Further, these stents possess superior radial force compared to their polymeric counterparts. This attribute is crucial in scenarios where stent expansion and resistance to compression are essential, such as in the treatment of strictures or areas prone to external compression. The enhanced radial force of metal stents contributes to their effectiveness in maintaining ureteral patency under challenging conditions, contributing to market growth positively.
     
Ureteral Stents Market, By End-use (2023)

The ureteral stents market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment dominates the market with a revenue of around USD 228.3 million in 2023.

  • Hospitals house skilled urologists, surgeons, and interventional radiologists who are adept at performing procedures involving ureteral stents. Surgical expertise is particularly vital in cases requiring complex interventions, such as stent placement post-surgery or in the management of challenging anatomical conditions. Hospitals' capacity for interventional procedures ensures that patients receive specialized care tailored to their unique urological needs.
     
  • Moreover, hospitals are equipped with advanced diagnostic facilities, including imaging modalities such as fluoroscopy, ultrasound, and CT scans. These technologies are crucial for the precise placement of ureteral stents. The accessibility of cutting-edge diagnostic tools within hospital settings enhances the accuracy and efficacy of ureteral stent procedures, contributing to their widespread adoption.
     
North America Ureteral Stents Market, 2020 – 2032 (USD Million)

North America ureteral stents market accounted for USD 190.6 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

  • North America experiences a significant prevalence of urological disorders, including conditions such as kidney stones, urinary tract infections (UTIs), and bladder-related issues. For instance, according to an article published by Medscape, in 2023, UTIs account for over 6 million patient visits to physicians per year in the U.S. The increasing incidence of these disorders has propelled the demand for ureteral stents, making North America a dominant market for these essential medical devices.
     
  • Moreover, North America is at the forefront of adopting and implementing technological innovations in the field of healthcare. The region consistently embraces new developments in medical devices, diagnostic tools, and treatment modalities. This includes the integration of advanced imaging technologies for precise stent placement and the use of novel materials in ureteral stent design. The rapid adoption of these innovations contributes to the dominance of North America in the global market.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Ureteral stents industry was worth USD 470.6 million in revenue in 2023 and is expected to expand at 6% CAGR from 2024-2032 attributed to the increasing prevalence of urological disorders coupled with the rising need for minimally invasive procedures.

The double pigtail segment accounted for USD 177.8 million in revenue in 2023 and is estimated to record substantial growth through 2032 owing to the unique design innovation of ureteral stents, contributing to their widespread use and acceptance in urological interventions.

North America ureteral stents market generated USD 190.6 million in revenue in 2023 and is set to exhibit robust growth during 2024-2032 driven by the significant prevalence of urological disorders, including conditions, such as kidney stones, UTIs, and bladder-related issues.

Some of the major companies operating in the ureteral stents industry are Allium Medical, B.Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Coloplast, Cook Medical, Olympus Corporation, Pnn Medical A/S, Teleflex Inc., and Uromed.

Ureteral Stents Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 306
  • Countries covered: 22
  • Pages: 180
 Download Free Sample